According to recently released documents, the FDA acknowledged deviating from the normal vaccination approval process when dealing with Pfizer's COVID-19 vaccine approval.
A U.S. Food and Drug Administration official issued a memo allowing the publication of a Biologics License Application (BLA) number for the injection weeks after Pfizer and its partner BioNTech revealed they began a rolling submission of documentation for approval of their COVID-19 vaccine. One of the documents (pdf be...
